Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Diseases

  Free Subscription


06.05.2019

2 AJR Am J Roentgenol
1 Biochem Biophys Res Commun
2 BMC Cancer
1 Br J Surg
3 Dig Dis Sci
1 Endoscopy
1 Eur Radiol
4 Gastroenterology
7 Hepatology
2 J Gastroenterol Hepatol
1 J Hepatol
1 J Pediatr
1 J Pediatr Surg
1 Lancet Gastroenterol Hepatol
1 Lancet Infect Dis
1 Radiology
2 Semin Liver Dis
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. VERNUCCIO F, Cannella R, Meyer M, Choudhoury KR, et al
    LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement.
    AJR Am J Roentgenol. 2019 Apr 30:1-9. doi: 10.2214/AJR.18.20979.
    PubMed     Text format     Abstract available

  2. KIM HO, Yim NY, Kim JK, Kang YJ, et al
    Change in Perfusion Angiography During Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Predicts Short-Term Outcomes.
    AJR Am J Roentgenol. 2019 Apr 30:1-8. doi: 10.2214/AJR.18.20499.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  3. QIAO Y, Li X, Zhang X, Xiao F, et al
    Hepatocellular iNOS protects liver from NASH through Nrf2-dependent activation of HO-1.
    Biochem Biophys Res Commun. 2019 Apr 28. pii: S0006-291X(19)30794.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. WANG E, Xia D, Bai W, Yuan J, et al
    Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma.
    BMC Cancer. 2019;19:409.
    PubMed     Text format     Abstract available

  5. LI W, Liao X, Ning P, Cao Y, et al
    Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
    BMC Cancer. 2019;19:395.
    PubMed     Text format     Abstract available


    Br J Surg

  6. BJORNELV GMW, Dueland S, Line PD, Joranger P, et al
    Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver.
    Br J Surg. 2019;106:132-141.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  7. LI X, Jiang F, Ge Z, Chen B, et al
    Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05642.
    PubMed     Text format     Abstract available

  8. ZOU WY, Choi K, Kramer JR, Yu X, et al
    Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05641.
    PubMed     Text format     Abstract available

  9. DEMORROW S
    Concise Commentary: Staying True to Type-The Increasing Inpatient Burden of Hepatic Encephalopathy.
    Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05630.
    PubMed     Text format    


    Endoscopy

  10. KAWAKAMI Y, Kanno Y, Koshita S, Ogawa T, et al
    Endoscopic ultrasound-guided hepaticoduodenostomy for an obstructed anterior hepatic branch in a patient with Billroth-II reconstruction.
    Endoscopy. 2019 Apr 30. doi: 10.1055/a-0885-9348.
    PubMed     Text format    


    Eur Radiol

  11. ABE H, Midorikawa Y, Matsumoto N, Moriyama M, et al
    Prediction of esophageal varices by liver and spleen MR elastography.
    Eur Radiol. 2019 Apr 30. pii: 10.1007/s00330-019-06230.
    PubMed     Text format     Abstract available


    Gastroenterology

  12. KIM HP, Moon AM, Dellon ES
    Noninvasively Predicting Hemodynamic Response to Carvedilol in Cirrhotic Patients with Varices: You Have Some Ex-Spleening to Do.
    Gastroenterology. 2019 Apr 26. pii: S0016-5085(19)36721.
    PubMed     Text format    

  13. ROOS FJM, IJzermans JNM, van der Laan LJW
    Reply to "Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies from Patients with Liver Disease": Implications for Transplant Chimerism.
    Gastroenterology. 2019;156:1932-1933.
    PubMed     Text format    

  14. WANG J, Dong R, Zheng S
    Circulating Epithelial Cells in Patients With Liver Disease.
    Gastroenterology. 2019;156:1932.
    PubMed     Text format    

  15. BHAN I, Aryee M, Ting DT
    Reply.
    Gastroenterology. 2019;156:1933-1934.
    PubMed     Text format    


    Hepatology

  16. STARLINGER P, Pereyra D, Hackl M, Assinger A, et al
    miRNA Signatures in Cirrhotic Patients.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30682.
    PubMed     Text format     Abstract available

  17. BADAWY AA
    The Kynurenine Pathway in Hepatic Cirrhosis.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30680.
    PubMed     Text format     Abstract available

  18. CHEUNG A, Neuschwander-Tetri BA, Kleiner DE, Schabel E, et al
    Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations from the Liver Forum.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30672.
    PubMed     Text format     Abstract available

  19. BHANJI RA, Montano-Loza AJ, Watt KD
    SARCOPENIA IN CIRRHOSIS: Looking beyond the skeletal muscle loss to see the systemic disease.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30686.
    PubMed     Text format     Abstract available

  20. ALISON MR, Lin WR
    Periportal Sox9-positive hepatocytes: progenitors with a biliary leaning.
    Hepatology. 2019 Apr 29. doi: 10.1002/hep.30687.
    PubMed     Text format     Abstract available

  21. BAJAJ JS, Salzman NH, Acharya C, Sterling RK, et al
    Fecal Microbial Transplant Capsules are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.
    Hepatology. 2019 Apr 30. doi: 10.1002/hep.30690.
    PubMed     Text format     Abstract available

  22. NARDELLI S, Lattanzi B, Merli M, Farcomeni A, et al
    Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis.
    Hepatology. 2019 Apr 30. doi: 10.1002/hep.30692.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  23. JIANG X, Liu F, Wang Y, Gao J, et al
    SPARC promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancer stem cell phenotypes.
    J Gastroenterol Hepatol. 2019 Apr 30. doi: 10.1111/jgh.14692.
    PubMed     Text format     Abstract available

  24. ZHANG C, Ge S, Wang J, Jing X, et al
    Epigenomic Profiling of DNA Methylation Reveals New Potential Biomarkers for Hepatocellular Carcinoma Diagnosis and Prognosis Prediction.
    J Gastroenterol Hepatol. 2019 Apr 30. doi: 10.1111/jgh.14694.
    PubMed     Text format     Abstract available


    J Hepatol

  25. HUTCHINSON JA, Schlitt HJ
    Subclinical T cell-mediated liver transplant rejection: The jury is still out.
    J Hepatol. 2018 Jun 30. pii: S0168-8278(18)32157.
    PubMed     Text format    


    J Pediatr

  26. LONG SS
    50 Years Ago in The Journal of Pediatrics: Pyogenic Hepatic Abscess in Infancy and Childhood.
    J Pediatr. 2019;208:103.
    PubMed     Text format    


    J Pediatr Surg

  27. BAKER MA, Nandivada P, Mitchell PD, Fell GL, et al
    Omega-3 fatty acids are protective in hepatic ischemia reperfusion injury in the absence of GPR120 signaling.
    J Pediatr Surg. 2019 Apr 12. pii: S0022-3468(19)30262.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  28. PENG JK, Higginson IJ, Gao W
    Place of death and factors associated with hospital death in patients who have died from liver disease in England: a national population-based study.
    Lancet Gastroenterol Hepatol. 2019;4:52-62.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  29. WU K, Feng X, Liu X, Wang W, et al
    Residual cavity hydrops initially misdiagnosed as recurrent hepatic echinococcosis.
    Lancet Infect Dis. 2019;19:557.
    PubMed     Text format    


    Radiology

  30. GUIU B, Chevallier P, Assenat E, Barbier E, et al
    Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial.
    Radiology. 2019 Apr 30:182399. doi: 10.1148/radiol.2019182399.
    PubMed     Text format     Abstract available


    Semin Liver Dis

  31. NAULT JC, Letouze E
    Mutational Processes in Hepatocellular Carcinoma: The Story of Aristolochic Acid.
    Semin Liver Dis. 2019 Apr 30. doi: 10.1055/s-0039-1685516.
    PubMed     Text format     Abstract available

  32. FEHILY SR, Papaluca T, Thompson AJ
    Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review.
    Semin Liver Dis. 2019 Apr 30. doi: 10.1055/s-0039-1685538.
    PubMed     Text format     Abstract available


    Transplantation

  33. ISSA F
    Proteomics Identifies New Therapeutic Targets of Early-stage Hepatocellular Carcinoma.
    Transplantation. 2019;103:855-856.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: